What is the recommended dose of Ceftin (cefuroxime) for a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftin (Cefuroxime) Dosing for UTI

For uncomplicated urinary tract infections, cefuroxime axetil (Ceftin) should be dosed at 250 mg orally twice daily for 7-10 days. 1, 2

Dosing by UTI Type

Uncomplicated Cystitis (Lower UTI)

  • Standard dose: 250 mg orally twice daily for 7-10 days 2, 3, 4
  • Alternative: 125 mg twice daily has shown effectiveness in some uncomplicated cases 2
  • Clinical studies demonstrate 86-97% cure rates with this regimen 3, 4

Uncomplicated Pyelonephritis (Upper UTI)

  • Oral cephalosporins are NOT first-line agents for pyelonephritis due to lower efficacy compared to fluoroquinolones 5
  • If oral cephalosporins like cefuroxime are used, an initial IV dose of a long-acting parenteral agent (e.g., ceftriaxone 1g) should be administered first 5
  • Duration: 10-14 days when using oral beta-lactams 5

Complicated UTI

  • Parenteral cefuroxime: 750 mg IV every 8 hours for uncomplicated UTI 1
  • Severe/complicated infections: 1.5 grams IV every 8 hours 1
  • Oral formulations are generally inadequate for complicated UTI without initial parenteral therapy 5

Important Clinical Considerations

When Cefuroxime is Appropriate

  • Beta-lactamase producing organisms (E. coli, Klebsiella) where cefuroxime maintains activity 3, 4
  • Patients with fluoroquinolone allergy or contraindication requiring an alternative agent 5
  • Uncomplicated lower UTI where local resistance patterns support use 5

Critical Limitations

  • Oral beta-lactams are less effective than fluoroquinolones or trimethoprim-sulfamethoxazole for pyelonephritis 5
  • Should not be used as monotherapy for pyelonephritis without initial parenteral long-acting agent 5
  • Local susceptibility patterns must guide selection - E. coli resistance varies geographically 5

Dosing Frequency Evidence

  • Twice-daily dosing (250 mg BID) is as effective as more frequent dosing for uncomplicated UTI 3, 6
  • Single daily dosing (250 mg once daily at night) showed 86% cure rate but is not standard practice 3
  • Twice-daily dosing improves adherence compared to four-times-daily regimens 6

Renal Impairment Adjustments

  • CrCl >20 mL/min: Standard dosing (750 mg-1.5g IV every 8 hours) 1
  • CrCl 10-20 mL/min: 750 mg IV every 12 hours 1
  • CrCl <10 mL/min: 750 mg IV every 24 hours; additional dose after hemodialysis 1

Common Pitfalls

  • Do not use for febrile UTI/pyelonephritis without initial IV therapy - this is a critical error that reduces efficacy 5
  • Avoid empiric use without considering local E. coli resistance patterns 5
  • Gastrointestinal adverse effects (diarrhea 4-5%, candida vaginitis 8%) are common; twice-daily dosing may reduce GI effects compared to once-daily 2, 3, 4
  • Do not use doses below 250 mg BID for active infection 1

References

Research

Cefuroxime axetil.

International journal of antimicrobial agents, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.